Related Experiment Video
Updated: Jan 24, 2026

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells
Published on: March 28, 2021
Concise Review: Stem Cell Therapy for Stroke Patients: Are We There Yet?
1Center of Excellence for Aging and Brain Repair, Department of Neurosurgery and Brain Repair, University of South Florida Morsani College of Medicine, Tampa, Florida, USA.
Abstract:
Four decades of preclinical research demonstrating survival, functional integration, and behavioral effects of transplanted stem cells in experimental stroke models have provided ample scientific basis for initiating limited clinical trials of stem cell therapy in stroke patients. Although safety of the grafted cells has been overwhelmingly documented, efficacy has not been forthcoming. Two recently concluded stroke clinical trials on mesenchymal stem cells (MSCs) highlight the importance of strict adherence to the basic science findings of optimal transplant regimen of cell dose, timing, and route of delivery in enhancing the functional outcomes of cell therapy. Echoing the Stem Cell Therapeutics as an Emerging Paradigm for Stroke and Stroke Treatment Academic Industry Roundtable call for an NIH-guided collaborative consortium of multiple laboratories in testing the safety and efficacy of stem cells and their derivatives, not just as stand-alone but preferably in combination with approved thrombolytic or thrombectomy, may further increase the likelihood of successful fruition of translating stem cell therapy for stroke clinical application. The laboratory and clinical experience with MSC therapy for stroke may guide the future translational research on stem cell-based regenerative medicine in neurological disorders. Stem Cells Translational Medicine 2019;8:983&988.
Insights
Decades of preclinical stem cell research support clinical trials for stroke. However, recent trials show efficacy is lacking, emphasizing the need for optimal cell therapy regimens and combinations for successful stroke treatment.
Area of Science:
- Regenerative Medicine
- Neuroscience
- Translational Research
Background:
- Extensive preclinical data support stem cell therapy for stroke.
- Clinical trials have shown safety but not efficacy of stem cell transplantation in stroke patients.
Purpose of the Study:
- To review the current status of stem cell therapy for stroke.
- To highlight the importance of optimizing transplant parameters for efficacy.
- To propose future research directions for stem cell-based stroke treatment.
Main Methods:
- Review of preclinical research and clinical trial data on stem cell therapy for stroke.
- Analysis of factors influencing stem cell therapy outcomes, including cell dose, timing, and delivery route.
- Discussion of recommendations from the Stem Cell Therapeutics as an Emerging Paradigm for Stroke and Stroke Treatment Academic Industry Roundtable.
Main Results:
- Preclinical studies demonstrate stem cell survival, integration, and functional effects in experimental stroke models.
- Recent clinical trials with mesenchymal stem cells (MSCs) underscore the critical need for precise adherence to optimal transplant regimens.
- Efficacy in clinical settings has not yet been consistently demonstrated, despite proven safety.
Conclusions:
- Translating stem cell therapy for stroke requires strict adherence to basic science findings regarding optimal transplant conditions.
- Future research should focus on collaborative, NIH-guided consortia to test stem cells and derivatives, potentially in combination with established stroke treatments like thrombolysis or thrombectomy.
- Experience with MSCs in stroke provides valuable guidance for future stem cell-based regenerative medicine in neurological disorders.
More Related Videos
Related Concept Videos
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Induced Pluripotent Stem Cells
Adult Stem Cells
Embryonic Stem Cells

